medline.ch Psychiatrie Demenz

	Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial. Nat Med Edison P, Femminella GD, Ritchie C, Nowell J, Holmes C, Walker Z, Ridha B, Raza S, Livingston NR, Frangou E, Love S, Williams G, Lawrence R, Mcfarlane B, Archer H, Coulthard E, Underwood BR, Koranteng P, Karim S, Bannister C, Perneczky R, Prasanna A, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Holscher C, Mansouri A, Chester-Jones M, Holmes J, Tan T, Williams S, Ashraf A, Brooks DJ, Harrison J, Hinz R, Tadros G, Passmore AP, Ballard C. PMID: 41326666 [PubMed - as supplied by publisher]
	Comparing deep learning CNN method with traditional MRI-based hippocampal segmentation and volumetry for early Alzheimer's disease diagnosis across diverse populations. Sci Rep Ibrahim NSN, Suppiah S, Ibrahim B, Mohad Azmi NH, Seriramulu VP, Mohamad M, Hanafi M, Mohammad Sallehuddin H, Omar Sharif NN, Razali RM, Harrun NH. PMID: 41326490 [PubMed - as supplied by publisher]
	What can artificial intelligence bring to Alzheimer's disease clinical trials? A first perspective. J Prev Alzheimers Dis T Middleton L, Andrieu S. PMID: 41326298 [PubMed - as supplied by publisher]
	AI-augmented frameworks for enhancing Alzheimer's disease clinical trials: A memory clinic perspective. J Prev Alzheimers Dis Yigamawano FK, Odom AR, Xue C, Pandey HK, Kolachalama VB. PMID: 41326297 [PubMed - as supplied by publisher]
	Solving the 'Goldilocks problem' in dementia clinical trials with multimodal AI. J Prev Alzheimers Dis Welchman AE, Kourtzi Z. PMID: 41326296 [PubMed - as supplied by publisher]
	Excitation-inhibition imbalance as a common thread linking early Alzheimer's disease with temporal lobe epilepsy. Exp Neurol Okechukwu NG, Zaccone C, La Barbera L, Nobili A, D'amelio M. PMID: 41325895 [PubMed - as supplied by publisher]
	Postmenopausal Sarcopenia and Alzheimer's disease: The interplay of Mitochondria, Insulin resistance, and Myokines. Neurosci Biobehav Rev Farhana F, Sultana MA, Hia RA, Hegde V. PMID: 41325816 [PubMed - as supplied by publisher]
	End User and Primary Care Physicians' Perspectives on Digital Innovations in Dementia Risk Detection: Focus on a Digital Sleep Biomarker. JMIR Aging Mc Ardle R, Poole M, Horrocks S, King-Robson J, Schott JM, Sharp D, Harrison M, Robinson L. PMID: 41325603 [PubMed - indexed for MEDLINE]
	The interactions of copper, glutamate, and cuproptosis: insights into brain health and Alzheimer's disease pathology. Biometals Mousavi MA, Salarvandian S, Rafiee S, Mohammadi M, Khodagholi F, Javadpour P. PMID: 41324873 [PubMed - as supplied by publisher]
	Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials. CNS Drugs Abushakra S, Doraiswamy PM, Hey JA, Tosun D, Barkhof F, Barakos J, Petrella J, Kesslak JP, Power A, Sabbagh M, Porsteinsson A, Cohen S, Gauthier S, Ritchie C, Watson D, McSweeney E, Boada M, Liang E, Bracoud L, McLaine R, Flint S, Schaefer JF, Yu J, Bray M, Hendrix S, Dickson S, Durrant A, Albayrak A, Tolar M. PMID: 41324786 [PubMed - as supplied by publisher]
	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies. Mol Neurobiol Zhang L, Zhang L, Zhao J, Zhang W, Zhang H. PMID: 41324750 [PubMed - indexed for MEDLINE]
	Feasibility of an Alzheimer's Disease Care Pathway: Findings from an Educational Pilot in 2 Healthcare Systems. J Prim Care Community Health Bozoki A, Jain H, Olivarez M, Gallant S, Reeder S, Huntington-Alfano K. PMID: 41324281 [PubMed - indexed for MEDLINE]
	Effects of glucocerebrosidase gene variations on the risk of Parkinson's disease dementia: a meta-analysis. Front Aging Neurosci Li Q, Bi Z, Liang W, Yin S, Li H, Liang Z, Wu M, Quan J, Li C. PMID: 41323658 [PubMed]
	Structural and microstructural changes in white and gray matter across the Alzheimer's disease continuum. Front Aging Neurosci Lv L, Guo H, Zhao Z, Zhao X. PMID: 41323657 [PubMed]
	Scoping the Landscape of Deep Learning for Alzheimer's Disease Stage Classification: Methods, Challenges, and Opportunities. BME Front Sonko S, Houssam MI, Bissadu KD, O'Connor B, Hossain G. PMID: 41323574 [PubMed]
	The Utility of CSF Biomarkers in Diagnosing Alzheimer's Disease: A Thai Cohort Study. Dement Geriatr Cogn Dis Extra Nanthasi W, Rattanabannakit C, Wongkom N, Dujada P, Raksthaput A, Chaichanettee S, Phoyoo P, Wachirutmanggur L, An SSA, Senanarong V. PMID: 41323451 [PubMed]
	Current Best Practice for People with Frontotemporal Dementia in Norway: A Focus Group Study with Expert Healthcare Personnel. Dement Geriatr Cogn Dis Extra Mjørud M, Knapskog AB, Nåvik M, Røsvik J. PMID: 41323449 [PubMed]
	Study on the relationship between insomnia disorder, PET/CT, and gut microbiota in patients with Alzheimer's disease. Front Neurol Kang J, Chen J, Li P, Zhao S, Jing F, Xie J, Dong C. PMID: 41323221 [PubMed]
	Diagnostic utility of plasma p-tau217 differs by Alzheimer's disease tau-based subtypes. Alzheimers Dement (Amst) Hojjati SH, Butler TA, Zare SJM, Reihanian A, Khalafi M, Foldi N, Shah S, Jafari H, Li Y, Zhou L, Dartora W, Wartchow K, McIntire LBJ, Chiang GC, Alzheimer's Disease Neuroimaging Initiative. PMID: 41322377 [PubMed]
	Comparative efficacy and safety of symptomatic therapy and disease-modifying therapy for Alzheimer's disease: a systematic review and network meta-analysis. Front Neurosci Liu S, Zhao M, Liu Y, Yang X, Yan H, Xu H, Wu Y, Xu Y. PMID: 41322352 [PubMed]

Artikel 1 - 20 / 120962

Seite 1 von 6049



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung